$1.99
-0.06-2.93%
In chiusura: Sep 11, 5:00 PM EST
$2.32
0.3316.56%
Post-mercato: Aug 19, 6:17 PM EST

Aytu BioPharma (AYTU) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.40 | $-0.40 | $-0.14 | $-0.04 |
| Actual | $-0.53 | $-1.05 | $-0.08 | $-0.25 |
| Surprise | -32.5% | -162.5% | +42.9% | -525.0% |
| Revenue | ||||
| Estimate | $12.0M | $12.1M | $12.6M | $18.0M |
| Actual | $12.4M | $15.2M | $13.9M | $15.1M |
| Surprise | +3.06% | +25.2% | +10.3% | -15.8% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.32 | $-0.02 | $0.02 | $0.08 |
| Revenue | ||||
| Consensus | $12.1M | $17.2M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | May 13, 2026 | $-0.53 | $-0.40 | -32.5 % |
| Q2 | Feb 3, 2026 | $-1.05 | $-0.40 | -162.5 % |
| Q1 | Nov 13, 2025 | $-0.08 | $-0.14 | 42.9 % |
| Q4 | Sep 23, 2025 | $-0.25 | $-0.04 | -525.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | May 13, 2026 | $12.41M | $12.04M | 3.06 % |
| Q2 | Feb 3, 2026 | $15.17M | $12.11M | 25.2 % |
| Q1 | Nov 13, 2025 | $13.90M | $12.61M | 10.3 % |
| Q4 | Sep 23, 2025 | $15.14M | $17.98M | -15.8 % |